Categories: NewsPersonal Data

AxonDAO Unveils A+Voice: Pioneering Biometric AI Voice Collection

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CHEYENNE, Wyo., June 12, 2024 /PRNewswire/ — AxonDAO (Axon DAO LLC, Wyoming) proudly announces the launch of A+Voice, an innovative research platform designed to monitor vocal biomarkers. This platform is an exceptionally effective tool for the early detection and ongoing assessment of conditions such as Alzheimer’s, Parkinson’s, dementia, post-traumatic stress disorder (PTSD), and Huntington’s Disease.

Assessing vocal biomarkers can also evaluate fatigue and energy levels, which could help standardize safety monitoring within a range of professions, such as operators of commercial trucks, cars, and heavy machinery. Looking ahead, AxonDAO plans to enhance their models to also identify biomarkers that evaluate changes in anxiety, stress, and mood.

By using decentralized ledger technology, zero-knowledge security, and other advanced technologies, AxonDAO allows research participants to access, own, and control their health data. Through community engagement and transparent data collection, AxonDAO facilitates research studies on a scale larger than conventional approaches, whether conducted by academia or industry.

Introducing A+Voice

A+Voice is AxonDAO’s groundbreaking biometric AI voice collection and analysis software. The platform utilizes a reward system to collect high-quality, consistent voice data that runs through a quality assessment and analytical engine. By utilizing blockchain technology, A+Voice timestamps, anonymizes, and processes this data into patterned AI processes while adhering to stringent HIPAA and ISO 27001 compliance standards for secure data handling.

Strategic Collaborations and Milestones

The recent approval of AxonDAO for NVIDIA’s Inception Program on October 27, 2023, highlights its dedication to excellence. Last March, the AxonDAO team showcased its vision at NVIDIA’s GTC event in San Jose, California.

Strategic partnerships have bolstered the launch of A+Voice:

  • NVIDIA: Facilitating the scaling of A+Voice and products through cutting-edge GPU processors.
  • 639 Solar: Hosting AxonDAO’s DeSci Research Toolkit and Computational Engine in one of the world’s largest solar-powered data centers.
  • DataLake: Delivering industry standards in consent management, which includes user rights to revoke personal data access.

AxonDAO’s Vision and Market Potential

AxonDAO is dedicated to nurturing human relationships and advancing scientific research through biometric data. The personal data market, currently valued at $1.61 trillion, is projected to grow to $17.06 trillion by 2029 with the integration of high-quality biometric data.

AxonDAO on Mario’s Roundtable X Account

AxonDAO will be featured on Mario’s Roundtable X account THIS Thursday, June 13th, at 12:00 PM EST. Join the session to learn more about AxonDAO’s groundbreaking work and its vision for the future of decentralized science.AxonDAO’s and team is scheduled for several X Space calls with Mario in the coming weeks.

About $AXGT

AxonDAO’s governance token, $AXGT, is an Ethereum-based token with bridges to Arbitrum and BASE coming soon. $AXGT is undergoing a security audit by Certik. The token is available on UniSwap and will be submitted for listing on major Tier 1 exchanges for easier access. $AXGT’s utility includes voting on projects to be funded, submitting projects, use in  data collection within the AxonDAO ecosystem, and more. The current market cap is $44.7M, with a fully diluted valuation (FDV) of $271M, and is currently priced at $0.271 per $AXGT.

For more information, visit axondao.io.

About AxonDAO

AxonDAO is a decentralized autonomous organization focused on building, funding, and supporting scientific research using biometric data. By harnessing the power of blockchain and AI, AxonDAO aims to revolutionize how biometric data is collected, processed, and utilized for scientific advancements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/axondao-unveils-avoice-pioneering-biometric-ai-voice-collection-302170877.html

SOURCE AxonDAO

Staff

Recent Posts

University of Arizona Study Finds Openwater’s Open-LIFU 2.0 Device Achieves Significant Depression Symptom Reduction After Less Than Two Hours Total Treatment Time

Clinical Trial Utilizing Low-Intensity Transcranial Focused Ultrasound Pulses to Key Brain Region Shows Notable Reduction…

2 hours ago

Alcon Publishes Agenda for 2025 Annual General Meeting

Alcon welcomes its shareholders to its third in-person AGM Alcon Board of Directors proposes to…

5 hours ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

5 hours ago

BIZCLIK MEDIA PUBLISHES APRIL EDITION OF HEALTHCARE DIGITAL

The April edition of Healthcare Digital features exclusive insights from leaders at Abzena, Arcutis Biotherapeutics, Spotfire, S&P…

5 hours ago

TALON selects Litchfield Underwriters to provide Comprehensive Stop-Loss Coverage for Transformative Equitable Healthcare Pricing Network

PORTSMOUTH, N.H., April 4, 2025 /PRNewswire/ -- Litchfield Underwriters, industry leaders in providing superior self-funded…

5 hours ago

Google Cloud and Ai2 Commit $20M to Advance AI-Powered Research for the Cancer AI Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and…

5 hours ago